Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SONATINA: Nelfinavir Added to Short-Course Radiotherapy in Neoadjuvant Treatment of Rectal Cancer
2010-020621-40Phase 2Terminated
- Sponsor
- University of Oxford
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nelfinavir in rectal adenocarcinoma (2 arms), sponsored by University of Oxford. Primary endpoint: Primary safety and activity endpoint. Started Aug 2010; status: terminated.
02
Drugs
nelfinavir
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on 2010-020621-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020621-40.